{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:39:34Z","timestamp":1789184374818,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/cmi.2016.31","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T08:43:19Z","timestamp":1467621799000},"page":"830-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-\u043aB signaling pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Ran","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"BFcmi201631_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-007-9466-x","volume":"303","author":"C Peng","year":"2007","unstructured":"Peng C, Liu HY, Zhou M, Zhang LM, Li XL, Shen SR et al. BRD7 suppresses the growth of nasopharyngeal carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem 2007; 303: 141\u2013149.","journal-title":"Mol Cell Biochem"},{"key":"BFcmi201631_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jcp.20013","volume":"200","author":"J Zhou","year":"2004","unstructured":"Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras\/MEK\/ERK and Rb\/E2F pathways. J Cell Physiol 2004; 200: 89\u201398.","journal-title":"J Cell Physiol"},{"key":"BFcmi201631_CR3","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.18632\/oncotarget.1816","volume":"5","author":"K Hu","year":"2014","unstructured":"Hu K, Liao D, Wu W, Han AJ, Shi HJ, Wang F et al. Targeting the anaphase-promoting complex\/cyclosome (APC\/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma. Oncotarget 2014; 5: 3088\u20133100.","journal-title":"Oncotarget"},{"key":"BFcmi201631_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1158\/1078-0432.CCR-13-1271","volume":"20","author":"YA Park","year":"2014","unstructured":"Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH et al. Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clin Cancer Res 2014; 20: 565\u2013575.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201631_CR5","first-page":"123","volume":"22","author":"M Zhou","year":"2003","unstructured":"Zhou M, Peng C, Nie XM, Zhang BC, Zhu SG, Yu Y et al. [Expression of BRD7-interacting proteins,BRD2 and BRD3, in nasopharyngeal carcinoma tissues]. Ai Zheng 2003; 22: 123\u2013127.","journal-title":"Ai Zheng"},{"key":"BFcmi201631_CR6","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1093\/nar\/gks342","volume":"40","author":"BD Berkovits","year":"2012","unstructured":"Berkovits BD, Wang L, Guarnieri P, Wolgemuth DJ . The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3\u2032-UTR truncation in round spermatids. Nucleic Acids Res 2012; 40: 7162\u20137175.","journal-title":"Nucleic Acids Res"},{"key":"BFcmi201631_CR7","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1021\/jm501893k","volume":"58","author":"S Picaud","year":"2015","unstructured":"Picaud S, Strocchia M, Terracciano S, Lauro G, Mendez J, Daniels DL et al. 9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain. J Med Chem 2015; 58: 2718\u20132736.","journal-title":"J Med Chem"},{"key":"BFcmi201631_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbrc.2007.04.139","volume":"358","author":"H Sun","year":"2007","unstructured":"Sun H, Liu J, Zhang J, Shen W, Huang H, Xu C et al. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochem Biophys Res Commun 2007; 358: 435\u2013441.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcmi201631_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/jcb.20788","volume":"98","author":"M Zhou","year":"2006","unstructured":"Zhou M, Liu H, Xu X, Zhou H, Li X, Peng C et al. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem 2006; 98: 920\u2013930.","journal-title":"J Cell Biochem"},{"key":"BFcmi201631_CR10","doi-asserted-by":"publisher","first-page":"32254","DOI":"10.1074\/jbc.M806061200","volume":"283","author":"MD Kaeser","year":"2008","unstructured":"Kaeser MD, Aslanian A, Dong MQ, Yates JR, Emerson BM . BRD7, a novel PBAF-specific SWI\/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 2008; 283: 32254\u201332263.","journal-title":"J Biol Chem"},{"issue":"3-4","key":"BFcmi201631_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10911-015-9333-4","volume":"20","author":"Honor J. Hugo","year":"2015","unstructured":"Hugo HJ, Saunders C, Ramsay RG, Thompson EW . New insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis. J Mammary Gland Biol Neoplasia 2015; e-pub ahead of print 21 July 2015 doi:10.1007\/s10911-015-9333-4.","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"BFcmi201631_CR12","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/0008-5472.CAN-15-0125","volume":"75","author":"X Ma","year":"2015","unstructured":"Ma X, Aoki T, Tsuruyama T, Narumiya S . Definition of prostaglandin E2-EP2 Signals in the colon tumor microenvironment that amplify inflammation and tumor growth. Cancer Res 2015; 75: 2822\u20132832.","journal-title":"Cancer Res"},{"key":"BFcmi201631_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12253-015-9913-z","volume":"21","author":"JV Fernandes","year":"2015","unstructured":"Fernandes JV, Cobucci RN, Jatoba CA, de Medeiros FT, de Azevedo JW, de Araujo JM . The role of the mediators of inflammation in cancer development. Pathol Oncol Res 2015; 21: 527\u2013534.","journal-title":"Pathol Oncol Res"},{"key":"BFcmi201631_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-7-17","volume":"7","author":"ZW Dong","year":"2014","unstructured":"Dong ZW, Ren CG, Xia Y, Su D, Du TT, Fan HB et al. Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafish. J Hematol Oncol 2014; 7: 17.","journal-title":"J Hematol Oncol"},{"key":"BFcmi201631_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/carcin\/bgu134","volume":"35","author":"T Cooks","year":"2014","unstructured":"Cooks T, Harris CC, Oren M . Caught in the cross fire: p53 in inflammation. Carcinogenesis 2014; 35: 1680\u20131690.","journal-title":"Carcinogenesis"},{"key":"BFcmi201631_CR16","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/carcin\/bgr131","volume":"32","author":"T Schmid","year":"2011","unstructured":"Schmid T, Bajer MM, Blees JS, Eifler LK, Milke L, Rubsamen D et al. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation. Carcinogenesis 2011; 32: 1427\u20131433.","journal-title":"Carcinogenesis"},{"key":"BFcmi201631_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2015.02.031","volume":"286","author":"Y Xu","year":"2015","unstructured":"Xu Y, Cao W, Zhou M, Li C, Luo Y, Wang H et al. Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. Behav Brain Res 2015; 286: 1\u201310.","journal-title":"Behav Brain Res"},{"key":"BFcmi201631_CR18","doi-asserted-by":"publisher","first-page":"21776","DOI":"10.1038\/srep21776","volume":"6","author":"H Wang","year":"2016","unstructured":"Wang H, Zhao R, Guo C, Jiang S, Yang J, Xu Y et al. Knockout of BRD7 results in impaired spermatogenesis and male infertility. Sci Rep 2016; 6: 21776.","journal-title":"Sci Rep"},{"key":"BFcmi201631_CR19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0161-5890(97)00145-4","volume":"34","author":"K Tominaga","year":"1997","unstructured":"Tominaga K, Kirikae T, Nakano M . Lipopolysaccharide (LPS)-induced IL-6 production by embryonic fibroblasts isolated and cloned from LPS-responsive and LPS-hyporesponsive mice. Mol Immunol 1997; 34: 1147\u20131156.","journal-title":"Mol Immunol"},{"key":"BFcmi201631_CR20","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1038\/srep09047","volume":"5","author":"T Ren","year":"2015","unstructured":"Ren T, Tian T, Feng X, Ye S, Wang H, Wu W et al. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-kappaB signaling pathway. Sci Rep 2015; 5: 9047.","journal-title":"Sci Rep"},{"key":"BFcmi201631_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, Neurath MF . Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541\u2013546.","journal-title":"Nat Protoc"},{"key":"BFcmi201631_CR22","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ . Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238\u2013249.","journal-title":"Lab Invest"},{"issue":"4","key":"BFcmi201631_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1179\/1973947815Y.0000000060","volume":"28","author":"Priyanka Rani","year":"2016","unstructured":"Rani P, Pal D, Hegde RR, Hashim SR . Acetamides: chemotherapeutic agents for inflammation-associated cancers. J Chemother 2015 e-pub ahead of print 21 July 2015 doi:10.1179\/1973947815Y.0000000060.","journal-title":"Journal of Chemotherapy"},{"key":"BFcmi201631_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00011-015-0852-7","volume":"64","author":"F Mao","year":"2015","unstructured":"Mao F, Wang M, Wang J, Xu WR . The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer. Inflamm Res 2015; 64: 661\u2013669.","journal-title":"Inflamm Res"},{"key":"BFcmi201631_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12253-015-9913-z","volume":"21","author":"JV Fernandes","year":"2015","unstructured":"Fernandes JV, Cobucci RN, Jatoba CA, de Medeiros FT, de Azevedo JW, de Araujo JM . The role of the mediators of inflammation in cancer development. Pathol Oncol Res 2015; 21: 527\u2013534.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"BFcmi201631_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/cmi.2015.47","volume":"13","author":"Yang Jiang","year":"2015","unstructured":"Jiang Y, Gao Q, Wang L, Guo C, Zhu F, Wang B et al. Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice. Cell Mol Immunol 2015 e-pub ahead of print 13 July 2015 doi:10.1038\/cmi.2015.47.","journal-title":"Cellular & Molecular Immunology"},{"key":"BFcmi201631_CR27","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.4049\/jimmunol.177.11.8095","volume":"177","author":"A Hilliard","year":"2006","unstructured":"Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006; 177: 8095\u20138102.","journal-title":"J Immunol"},{"key":"BFcmi201631_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/pcmr.12282","volume":"27","author":"SJ Gallagher","year":"2014","unstructured":"Gallagher SJ, Mijatov B, Gunatilake D, Gowrishankar K, Tiffen J, James W et al. Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. Pigment Cell Melanoma Res 2014; 27: 1126\u20131137.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFcmi201631_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1128\/MCB.01353-13","volume":"34","author":"S Wienerroither","year":"2014","unstructured":"Wienerroither S, Rauch I, Rosebrock F, Jamieson AM, Bradner J, Muhar M et al. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins. Mol Cell Biol 2014; 34: 415\u2013427.","journal-title":"Mol Cell Biol"},{"key":"BFcmi201631_CR30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO . The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009; 458: 1191\u20131195.","journal-title":"Nature"},{"key":"BFcmi201631_CR31","first-page":"311","volume":"383","author":"H Sun","year":"2007","unstructured":"Sun H, Gulbagci NT, Taneja R . Analysis of growth properties and cell cycle regulation using mouse embryonic fibroblast cells. Methods Mol Biol 2007; 383: 311\u2013319.","journal-title":"Methods Mol Biol"},{"key":"BFcmi201631_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13075-015-0686-2","volume":"17","author":"V Fleischer","year":"2015","unstructured":"Fleischer V, Sieber J, Fleischer SJ, Shock A, Heine G, Daridon C et al. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients. Arthritis Res Ther 2015; 17: 185.","journal-title":"Arthritis Res Ther"},{"key":"BFcmi201631_CR33","first-page":"895","volume":"15","author":"Y Yamaguchi","year":"2006","unstructured":"Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M et al. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. Oncol Rep 2006; 15: 895\u2013901.","journal-title":"Oncol Rep"},{"key":"BFcmi201631_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/glia.20989","volume":"58","author":"BJ Baker","year":"2010","unstructured":"Baker BJ, Park KW, Qin H, Ma X, Benveniste EN . IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 2010; 58: 1082\u20131093.","journal-title":"Glia"},{"key":"BFcmi201631_CR35","doi-asserted-by":"publisher","first-page":"12144","DOI":"10.1038\/srep12144","volume":"5","author":"W Lu","year":"2015","unstructured":"Lu W, Xu Y, Shao X, Gao F, Li Y, Hu J et al. Uric acid produces an inflammatory response through activation of NF-kappaB in the hypothalamus: implications for the pathogenesis of metabolic disorders. Sci Rep 2015; 5: 12144.","journal-title":"Sci Rep"},{"key":"BFcmi201631_CR36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/biom5031266","volume":"5","author":"M Schuliga","year":"2015","unstructured":"Schuliga M . NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules 2015; 5: 1266\u20131283.","journal-title":"Biomolecules"},{"key":"BFcmi201631_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.prostaglandins.2015.05.001","volume":"121","author":"AG Berdyshev","year":"2015","unstructured":"Berdyshev AG, Kosiakova HV, Onopchenko OV, Panchuk RR, Stoika RS, Hula NM . N-Stearoylethanolamine suppresses the pro-inflammatory cytokines production by inhibition of NF-kappaB translocation. Prostaglandins Other Lipid Mediat 2015; 121: 91\u201396.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"BFcmi201631_CR38","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.archoralbio.2015.05.005","volume":"60","author":"CX Jian","year":"2015","unstructured":"Jian CX, Li MZ, Zheng WY, He Y, Ren Y, Wu ZM et al. Tormentic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts via inhibition of TLR4-mediated NF-kappaB and MAPK signalling pathway. Arch Oral Biol 2015; 60: 1327\u20131332.","journal-title":"Arch Oral Biol"},{"key":"BFcmi201631_CR39","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1056\/NEJMra043632","volume":"355","author":"JA Russell","year":"2006","unstructured":"Russell JA . Management of sepsis. N Engl J Med 2006; 355: 1699\u20131713.","journal-title":"N Engl J Med"},{"key":"BFcmi201631_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1172\/JCI10373","volume":"107","author":"T Collins","year":"2001","unstructured":"Collins T, Cybulsky MI . NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001; 107: 255\u2013264.","journal-title":"J Clin Invest"},{"key":"BFcmi201631_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.075","volume":"332","author":"F Chen","year":"2005","unstructured":"Chen F . Is NF-kappaB a culprit in type 2 diabetes? Biochem Biophys Res Commun 2005; 332: 1\u20133.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcmi201631_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301\u2013310.","journal-title":"Nat Rev Cancer"},{"key":"BFcmi201631_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00384-008-0544-7","volume":"24","author":"DK Zhang","year":"2009","unstructured":"Zhang DK, Cheng LN, Huang XL, Shi W, Xiang JY, Gan HT . Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation. Int J Colorectal Dis 2009; 24: 5\u201312.","journal-title":"Int J Colorectal Dis"},{"key":"BFcmi201631_CR44","first-page":"799","volume":"232","author":"EK Tai","year":"2007","unstructured":"Tai EK, Wu WK, Wong HP, Lam EK, Yu L, Cho CH . A new role for cathelicidin in ulcerative colitis in mice. Exp Biol Med (Maywood) 2007; 232: 799\u2013808.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFcmi201631_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jnutbio.2011.01.007","volume":"23","author":"EL Vieira","year":"2012","unstructured":"Vieira EL, Leonel AJ, Sad AP, Beltrao NR, Costa TF, Ferreira TM et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 2012; 23: 430\u2013436.","journal-title":"J Nutr Biochem"},{"key":"BFcmi201631_CR46","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1053\/j.gastro.2011.06.079","volume":"141","author":"HW Koon","year":"2011","unstructured":"Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I et al. Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology 2011; 141: 1852\u201363.e1-3.","journal-title":"Gastroenterology"},{"key":"BFcmi201631_CR47","doi-asserted-by":"publisher","first-page":"L947","DOI":"10.1152\/ajplung.2001.280.5.L947","volume":"280","author":"H Zhang","year":"2001","unstructured":"Zhang H, Porro G, Orzech N, Mullen B, Liu M, Slutsky AS . Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am J Physiol Lung Cell Mol Physiol 2001; 280: L947\u2013L954.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFcmi201631_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3851\/IMP2077","volume":"22","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Yang D, Li W, Wang B, Jiang Z, Li M . Antiviral activity of recombinant mouse beta-defensin 3 against influenza A virus in vitro and in vivo. Antivir Chem Chemother 2012; 22: 255\u2013262.","journal-title":"Antivir Chem Chemother"},{"key":"BFcmi201631_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","volume":"41","author":"B Rivas-Santiago","year":"2013","unstructured":"Rivas-Santiago B, Rivas SC, Castaneda-Delgado JE, Leon-Contreras JC, Hancock RE, Hernandez-Pando R . Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Int J Antimicrob Agents 2013; 41: 143\u2013148.","journal-title":"Int J Antimicrob Agents"},{"key":"BFcmi201631_CR50","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1128\/AAC.02044-12","volume":"57","author":"M Schlusselhuber","year":"2013","unstructured":"Schlusselhuber M, Torelli R, Martini C, Leippe M, Cattoir V, Leclercq R et al. The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice. Antimicrob Agents Chemother 2013; 57: 4615\u20134621.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 15","key":"BFcmi201631_CR51","first-page":"36","volume":"38","author":"T Hibi","year":"2003","unstructured":"Hibi T, Inoue N, Ogata H, Naganuma M . Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 2003; 38 (Suppl 15): 36\u201342.","journal-title":"J Gastroenterol"},{"key":"BFcmi201631_CR52","first-page":"13","volume":"6","author":"A Polgar","year":"2000","unstructured":"Polgar A, Brozik M, Toth S, Holub M, Hegyi K, Kadar A et al. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med Sci Monit 2000; 6: 13\u201318.","journal-title":"Med Sci Monit"},{"key":"BFcmi201631_CR53","first-page":"1956","volume":"141","author":"SJ van Deventer","year":"1997","unstructured":"van Deventer SJ . [Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy]. Ned Tijdschr Geneeskd 1997; 141: 1956\u20131959.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"BFcmi201631_CR54","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/ibd.20845","volume":"15","author":"JS Hyams","year":"2009","unstructured":"Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Kugathasan S, Evans J et al. Long-term outcome of maintenance infliximab therapy in children with Crohn\u2019s disease. Inflamm Bowel Dis 2009; 15: 816\u2013822.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201631","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2016.31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:06:56Z","timestamp":1672744016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFcmi201631"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2016.31","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}